The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
Submitted: April 3, 2015
Accepted: September 8, 2015
Published: March 31, 2016
Accepted: September 8, 2015
Abstract Views: 1986
PDF: 805
SUPPLEMENTARY MATERIAL: 310
SUPPLEMENTARY MATERIAL: 310
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Porcaro, A. B., Caruso, B., Terrin, A., De Luyk, N., Cacciamani, G., Corsi, P., Inverardi, D., De Marchi, D., Baldassarre, R., Cerruto, M., Ghimenton, C., Brunelli, M., Zecchini Antoniolli, S., Petrozziello, A., & Artibani, W. (2016). The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy. Archivio Italiano Di Urologia E Andrologia, 88(1), 17–22. https://doi.org/10.4081/aiua.2016.1.17
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.